NCT06100965View on ClinicalTrials.gov

Reduced-dose Alemtuzumab for Kidney Transplant Rejection

RecruitingOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2026

Conditions
Kidney Transplant Rejection
Trial Locations (1)

3015 GD

RECRUITING

Erasmus MC, Rotterdam

Sponsors
All Listed Sponsors
lead

Erasmus Medical Center

OTHER